Washizuka Shinsuke, Ikeda Akifumi, Kato Nobumasa, Kato Tadafumi
Laboratory for Molecular Dynamics of Mental Disorders, Brain Science Institute, RIKEN, Saitama, Japan.
Int J Neuropsychopharmacol. 2003 Dec;6(4):421-4. doi: 10.1017/S1461145703003778.
Although many investigators have been searching for genetic markers to predict lithium response in bipolar disorders, no genetic predictor has been established yet. We previously reported the association of mitochondrial DNA (mtDNA) 5178 and 10398 polymorphisms with bipolar disorder. The objective of this study is to clarify whether these mtDNA polymorphisms can predict response to maintenance lithium treatment in bipolar patients. We examined these polymorphisms and some clinical variables in 54 bipolar patients. A logistic regression analysis was performed and revealed that patients carrying the 10398A polymorphism showed a significantly better response to lithium (p=0.03). Some clinical variables such as sex, age at onset, and rapid cycling also showed a significant association with lithium response in univariate analysis (chi2 test, p&0.05). Our findings suggest that the mtDNA 10398 polymorphism might be related to maintenance lithium treatment response.
尽管许多研究人员一直在寻找预测双相情感障碍患者锂盐反应的基因标记,但尚未建立起基因预测指标。我们之前报道了线粒体DNA(mtDNA)5178和10398多态性与双相情感障碍的关联。本研究的目的是阐明这些mtDNA多态性是否能够预测双相情感障碍患者维持性锂盐治疗的反应。我们检测了54例双相情感障碍患者的这些多态性以及一些临床变量。进行了逻辑回归分析,结果显示携带10398A多态性的患者对锂盐治疗的反应显著更好(p=0.03)。在单因素分析(卡方检验,p<0.05)中,一些临床变量如性别、起病年龄和快速循环也与锂盐反应显著相关。我们的研究结果提示,mtDNA 10398多态性可能与维持性锂盐治疗反应有关。